3 Review(s)

The pilot plant scale-up process is crucial for transitioning from laboratory experiments to full-scale production, addressing personnel, space, and raw materials requirements. It ensures consistency and quality through structured approaches like SUPAC guidelines and platform technology, which introduce flexible manufacturing processes. Technology transfer (TT) involves moving innovations from R&D to production, with WHO guidelines emphasizing quality risk management and comprehensive documentation. Regulatory affairs ensure compliance with global standards, guiding drug approval processes from non-clinical development to clinical research and effective data submission.